Latest filing published 24 Jan 2022 for AMOEBA, €36k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fabrice Plasson is a declared insider of Amoeba (chief executive), with filings sourced from AMF. In total, 4 filings cover trades dated from 4 January 2021 to 19 January 2022.
On the open market, the record shows 3 purchases worth €36k and 1 sale worth €88k. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2022 to date brings 1 purchase and no sales.
Most recently, on 24 January 2022, the filings show an open-market purchase worth €36k in Amoeba. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations